Tamova 40 mg Tablet

Tamova 40 mg Tablet contains Tamoxifen citrate equivalent to Tamoxifen 40 mg (per tablet). Prescription required.

Treatment of estrogen receptor (ER) positive breast cancer, adjuvant therapy after surgery/radiotherapy/chemotherapy, metastatic breast cancer; may also be used for breast cancer risk reduction in high-risk patients as advised by doctor

Tamoxifen is a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in breast tissue, reducing estrogen-driven growth of breast cancer cells. In some other tissues it may show partial estrogen-like effects.

Tablet: take exactly as prescribed by the oncologist, usually once daily at the same time each day; can be taken with or without food. Swallow with water; do not stop therapy without medical advice.

Hot flashes, nausea, vomiting, vaginal discharge, menstrual irregularities, fatigue, headache, leg cramps, fluid retention, rash

Prescription-only anticancer hormone therapy. Increased risk of blood clots (DVT/PE) and stroke—seek urgent care for leg swelling/pain, chest pain, sudden breathlessness or weakness. Can increase risk of endometrial changes/cancer—report abnormal vaginal bleeding. May cause cataracts/vision changes. Use caution in patients with history of thromboembolism, hyperlipidemia, liver disease. Regular follow-up, gynecologic review when appropriate, and monitoring as advised are important.

Warfarin and other anticoagulants (increased bleeding risk/INR changes), strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, bupropion, quinidine) may reduce active metabolite and effectiveness, rifampicin may reduce levels, other hormonal therapies/estrogens may interfere, certain anticancer agents (monitor as directed)

Store at room temperature (below 25°C), protected from light and moisture. Keep in original pack and out of reach of children.

Tamoxifen 40 mg Tablet (generic), Nolvadex 40 mg Tablet, Tamox 40 mg Tablet, Tamifen 40 mg Tablet, Tamoxifen Citrate 40 mg Tablet